MARC details
| 000 -LEADER |
|---|
| fixed length control field |
04380nam a22005775i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231109085734.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230108s2022 si | s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9789811955587 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1007/978-981-19-5558-7 |
| Source of number or code |
doi |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
TR-AnTOB |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
TR-AnTOB |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 200 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MJCL |
| Source |
bicssc |
|
|---|
| Subject category code |
MED062000 |
| Source |
bisacsh |
|
|---|
| Subject category code |
MJCL |
| Source |
thema |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
QZ200EBK |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Hormone Related Cancer Mechanistic and Nanomedicines |
| Medium |
[electronic resource] : |
| Remainder of title |
Challenges and Prospects / |
| Statement of responsibility, etc. |
edited by Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Sarwar Beg, Khalid S Alharbi. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
1st ed. 2022. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Singapore : |
| Name of producer, publisher, distributor, manufacturer |
Springer Nature Singapore : |
| -- |
Imprint: Springer, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 347 ## - DIGITAL FILE CHARACTERISTICS |
|---|
| File type |
text file |
| Encoding format |
PDF |
| Source |
rda |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Chapter 1. Conventional Treatment Approaches in Hormonal Cancer Treatment and Challenges -- Chapter 2. Concept of Nanomedicine in Endocrine Hormone Cancer Treatment -- Chapter 3. Progress of Cancer Nanomedicine, Clinical Hurdles and Opportunities -- Chapter 4. Emergence of Nanohybrids in Hormonal Cancer Targeted Therapy -- Chapter 5. Conventional to Nanoscale-Based Carrier System in Management of Ovarian Cancer -- Chapter 6. Pancreatic Cancer Nanoparticles Targeted Therapy via Epidermal Growth Factor Receptor -- Chapter 7. Nanocarriers Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead -- Chapter 8. Pancreatic Cancer Treatment by Using of Theranostics Nanoparticles -- Chapter 9. Nanomedicine Based Combinational Therapy for Breast Cancer -- Chapter 10. Nano-Liposomal System for Breast Cancer Therapy -- Chapter 11. Conventional to Nanotherapeutic Strategies against Triple-Negative Breast Cancer -- Chapter 12. Effect of Thymoquinone and Its Delivery Through Using of Nanomedicine in Benign Prostatic Hyperplasia -- Chapter 13. Concept of Nanotechnology in Management of Neuroendocrine Tumours -- Chapter 14. Neurocognitive Underpinning of Neurological Disorders: The Role of Default Mode Network -- Chapter 15. Neuroendocrine Carcinoma of The Endometrium: Conventional Treatment Approach to Nanomedicine -- Chapter 16. Effective Luteinizing Hormone Drug Delivery by Gold Nanoparticles in Hormonal Cancer Treatment -- Chapter 17. Regulatory Landscapes in Approval of Cancer Vaccines. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The nanotheranostics sector provides a very promising strategy for monitoring drug biodistribution and pathology longitudinal processes by integrating the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membrane with carrying drugs, nanomaterials have been used for various biomedical applications. This book covers the progress made in hormone-related cancer and their management by nonmedicinal therapy for targeting the hormone regulated cancer with their clinical progress and clinical hurdles. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Oncology. |
|
|---|
| Topical term or geographic name entry element |
Hormones. |
|
|---|
| Topical term or geographic name entry element |
Cancer. |
|
|---|
| Topical term or geographic name entry element |
Oncology. |
|
|---|
| Topical term or geographic name entry element |
Hormone. |
|
|---|
| Topical term or geographic name entry element |
Cancers. |
| 653 #0 - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Endocrine System Diseases -- drug therapy |
|
|---|
| Uncontrolled term |
Nanomedicine |
|
|---|
| Uncontrolled term |
Neoplasms -- drug therapy |
|
|---|
| Uncontrolled term |
Theranostic Nanomedicine |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rahman, Mahfoozur. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
H Almalki, Waleed. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Alrobaian, Majed. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Beg, Sarwar. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
|
|---|
| Personal name |
Alharbi, Khalid S. |
| Relator term |
editor. |
| Relator code |
edt |
| -- |
http://id.loc.gov/vocabulary/relators/edt |
| 710 2# - ADDED ENTRY--CORPORATE NAME |
|---|
| Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-981-19-5558-7">https://doi.org/10.1007/978-981-19-5558-7</a> |
| Materials specified |
Springer eBooks |
| Public note |
Online access link to the resource |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
